Intellectual Property / Patent / Copyright

Pharmaceutical Innovation, Competition And Patent Law A Trilateral Perspective

Edited by Josef Drexl · Nari Lee
Edward Elgar Publishing July 2013

Specifications

ISBN-13
9780857932457
Publisher
Edward Elgar Publishing
Publication
July 2013
Format
Hardback , 336 pages
Jurisdiction
International ? Countri(es) for reference only

Details

Public health, safety and access to reasonably priced medicine are common policy goals of pharmaceutical regulations. As both the context for innovation and competitive structure change, industry actors dynamically challenge the balance between the incentive for protection and the achievement of those policy goals.

Considering the arguments from the perspectives of innovation, competition law and patent law, this book explores the difficult question of balancing protection with access, highlighting the difficulties in harmonization and coordination. The contributors to this book, including academics, judges and practitioners from Europe, the US and Japan, explore to what extent patent strategies and life-cycle management practices take advantage of patent laws and health-care regulation and disrupt the necessary balance between incentives for innovation and access to affordable medicine and health care.

Addressing fundamental questions in the field of pharmaceutical innovation, this book will appeal to scholars and practitioners in intellectual property, competition law and life sciences regulation, as well as pharmaceutical companies and regulators.

Table of Contents

Introduction

PART I: PATENT PROTECTION FOR PHARMACEUTICAL METHODS
1. The Patentability of Genetic Diagnostics in U.S. Law and Policy

2. Patentability of Pharmaceutical Innovations – The European Perspective

3. Patentability of Medical Methods in Japan

PART II: DATA EXCLUSIVITY AND PATENT TERM EXTENSION – CONVERGENCE OR DIVERGENCE 
4. Patent Term Restoration and Non-Patent Exclusivity in the United States

5. Clinical Data, Data Exclusivity and Private Investment Protection in Europe

6. Patent Term Extension in Japan – an Academic and Comparative Perspective

7. Recent United Kingdom Case Law On Supplementary Protection Certificates

8. Patent Term Extension in Japan – Focusing on the Pacif Capsule Decision

Apppendix Decision of Japanese Supreme Court, 28 April 2011

PART III: BALANCING INCENTIVES AND COMPETITION IN EUROPE
9. Strategic Patenting by Pharmaceutical Industry – Towards a Concept of Abusive Practices of Protection

10. Anticompetitive Marketing in the Context of Pharmaceutical Switching in Europe

11. AstraZeneca and the EU Sector Inquiry: When Do Patent Filings Violate Competition Law?

Index

About the Author

Edited by Josef Drexl, Director, Max Planck Institute for Intellectual Property and Competition Law, Munich, Germany and Nari Lee, Department of Accounting and Commercial Law, Hanken School of Economics, Helsinki, Finland

Out of stock
This title is currently unavailable for purchase.
  • Free HK shipping over HK$1,000
  • International shipping to 35+ countries

Recommended

You may also be interested in these books:

More titles from Intellectual Property / Patent / Copyright

View all